# A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects

> **NCT05196711** · PHASE1 · UNKNOWN · sponsor: **Maxinovel Pty., Ltd.** · enrollment: 78 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** MAX-40070
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05196711
- **Lead sponsor:** Maxinovel Pty., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-28
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-30
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05196711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05196711, "A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05196711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*